VisiCELL Medical Inc., founded in 2012, aims to revolutionize stem cell-based therapy for patients with currently incurable diseases. The company's innovative technology platform offers clinically applicable imaging tools, earning it the slogan "GPS for cell therapy." With a team of passionate scientists, engineers, and a radiologist, VisiCELL is committed to accelerating the development and market entry of biopharmaceutical products. Their latest milestone includes securing a $255.54K grant investment from the National Science Foundation on 24 February 2022. Based in the United States, VisiCELL Medical Inc. operates within the Biotechnology industry, marking a promising venture for potential investors.
No recent news or press coverage available for VisiCELL Medical Inc..